USCIS Policy
How USCIS Evaluates Co-Inventor Patent Records as Original Contributions Evidence in O-1A Petitions
A patent establishes novelty — but not significance. When the petitioner is one of many co-inventors, USCIS needs evidence of individual contribution and field impact that the patent document itself does not provide. Here is how to build that record correctly.
Patents and the original contributions criterion
The original contributions criterion under 8 C.F.R. § 214.2(o)(3)(iv)(D) requires evidence that the petitioner has made original scientific, scholarly, or business-related contributions of major significance in the field. Patents are among the most tangible forms of original contribution evidence: a patent represents a formal, government-adjudicated determination that the inventor contributed something novel and non-obvious to the field. For engineers, scientists, and technologists filing O-1A petitions, a patent portfolio is often the strongest evidence tier — or it is a source of evidentiary complications when the patents were granted to a team of co-inventors rather than to the petitioner alone.
The core question USCIS asks when evaluating patent evidence is not whether a patent exists but what the petitioner personally contributed to the invention and whether that contribution has been of major significance in the field. A petitioner who is one of 15 co-inventors on a broad portfolio patent owned by a large corporation, where the individual inventor's contribution was one narrow claim among hundreds, faces a different evidentiary challenge than a petitioner who was the lead inventor on a foundational patent with 200 or more forward citations and an active licensing program. The petition must answer the question of individual contribution and field significance for each patent it relies on, rather than treating the existence of the patent grant as self-sufficient evidence.
Field significance is the threshold that many patent-based O-1A petitions fail to establish. A patent establishes novelty and non-obviousness under 35 U.S.C. §§ 102 and 103 — legal standards for patentability — but it does not establish that the patented invention has been significant in the petitioner's field. An issued patent on a minor process improvement with no forward citations, no licensing activity, and no evidence of commercial adoption is legally valid but evidentially weak for the original contributions criterion. The petition must independently establish significance through citation evidence, licensing evidence, adoption evidence, or expert testimony about the patent's impact — and that work must be done for each relying patent, not assumed from the patent grant alone.
The regulation's standard for original contributions
The regulatory text at 8 C.F.R. § 214.2(o)(3)(iv)(D) requires evidence of original scientific, scholarly, or business-related contributions of major significance in the field. The USCIS Policy Manual elaborates that major significance means the contribution has had a major impact on the overall field — not merely within the petitioner's own institution or on the petitioner's own subsequent work. An invention that solved a problem within the petitioner's own research program but has not been adopted, cited, or recognized by other researchers or practitioners outside that program is unlikely to satisfy the major significance requirement, however technically sophisticated the invention may be.
The Policy Manual's examples of evidence for this criterion include patents specifically mentioned, expert letters describing the contribution's significance, citations to the contribution in published work, and evidence of adoption of the contribution by other practitioners in the field. For co-inventor situations, the Policy Manual does not provide specific guidance, leaving adjudicators to evaluate co-inventor petitions under the general individual contribution analysis used across the criteria: the petition must establish what the petitioner specifically contributed, not merely that the petitioner was a named inventor on a patent that satisfies the criterion at some aggregate level.
The original component of the standard is addressed by the patent grant itself — a patent is definitionally an original, novel, non-obvious invention. However, the regulation's full phrase is original scientific, scholarly, or business-related contributions of major significance, which means the original contribution must also be significant. The Patent Trial and Appeal Board's legal determination of patentability does not address significance; USCIS adjudicators make that determination independently based on the evidentiary record. This is why a large number of low-impact patents does not substitute for a smaller number of high-impact patents for the purposes of the O-1A original contributions criterion — volume without significance fails the standard.
Patent evidence that routinely satisfies the criterion
The most persuasive patent evidence for the original contributions criterion combines three elements: forward citation data showing that other researchers or practitioners have cited the patent in their own subsequent work, evidence of licensing activity establishing that the invention has been adopted by commercial actors willing to pay for access, and expert letters from recognized figures in the field who can describe the patent's technical significance relative to the state of the art. These three evidence types together address the major significance requirement from independent angles — the scientific community has cited it, the commercial market has paid for it, and recognized experts have attested to its importance in terms that address the criterion's language.
Forward citation data for issued patents is available through the USPTO's PatFT database, Google Patents, and specialized patent analytics services including Lens.org. A patent with 50 or more forward citations from multiple distinct assignees — meaning 50 or more times other companies or researchers have cited the patent in their own applications — is a concrete metric of field engagement. A petition should include a printout showing the citing patents, their assignees, and their filing dates. This demonstrates that the invention has been recognized as foundational by a range of subsequent innovators, not just by the petitioner's own institution. Citing patent data can be supplemented by citing publication data if the invention has also been referenced in academic literature.
Licensing activity documents the commercial community's determination that the invention has economic value sufficient to warrant royalty payments. A license agreement with a named commercial entity, even with financial terms redacted, establishes that a paying party determined the patent was worth licensing. For patents owned by a university or employer, the institution's technology transfer office can typically provide a letter confirming that the patent has been licensed to one or more commercial entities. Where specific revenue figures are unavailable, qualitative descriptions — noting the patent has been licensed to three commercial entities for use in the medical device sector — document the commercial adoption without disclosing confidential terms and satisfy the petition's evidentiary burden for the significance element.
Patent evidence that tends to underperform
A patent portfolio that consists primarily of continuation applications, divisional applications, or related applications covering incremental variations of a single core invention presents a weaker case than the number of patents alone might suggest. USCIS adjudicators who review the petition with a legal lens may observe that 15 patents from a single family do not represent 15 independent original contributions — they represent one original contribution documented through multiple related applications. The petition should identify the foundational application in any related patent family and present that as the original contribution, with the continuation and divisional applications noted as evidence of the original invention's commercial importance rather than as independent contributions.
A provisional application that was not pursued to an issued patent, or a patent application that is pending without an issued grant, does not establish an original contribution in the way an issued patent does. A pending application has not been adjudicated as novel, non-obvious, and useful by the patent office — it is a claim that may or may not ultimately be valid. Petitions that rely heavily on pending applications for the original contributions criterion are vulnerable to RFEs asking for evidence of the contribution's recognition, since without an issued patent the petition must establish significance entirely through expert letters and adoption evidence without the foundational legal determination of novelty that an issued grant provides.
A petitioner's name on a company patent filed by a team of engineers working on a standard product development project — a functional improvement to an existing commercial product, a new manufacturing process, a software feature — may represent standard employment output rather than an extraordinary contribution to the field. USCIS has held that patents resulting from normal employment duties, where the petitioner's contribution was one element of a team effort on an assigned engineering problem, do not necessarily establish original contributions of major significance. The petition must distinguish the patented invention from normal product development by establishing that it solved a problem the field had not been able to solve, was recognized by the scientific or engineering community as a significant advance, or has been adopted beyond the petitioner's employer's own product lines.
Co-inventor patents and individual contribution evidence
The co-inventor situation is the most common source of complexity in patent-based O-1A petitions. Under U.S. patent law, all individuals who contributed to the conception of at least one claim in the patent are required to be named as inventors; the inventorship determination is legal and technical, not based on seniority or employment status. A petitioner who is listed as one of eight co-inventors on a patent therefore may have contributed to a single narrow claim while others contributed to the core claims, or may have been the primary inventor of the most significant claims while others contributed peripheral ones. The patent itself does not disclose this internal distribution — that fact must be established through separate evidence.
To establish individual contribution for co-inventor patents, the petition should include a letter from the lead inventor, the supervising researcher, the patent attorney who prosecuted the patent, or another figure with direct knowledge of the inventive process who can describe the petitioner's specific contribution to the invention's conception. The letter should identify which claims the petitioner contributed to, describe the technical insight the petitioner provided, and explain why that contribution was essential to the patent rather than peripheral. A letter from the patent attorney of record — who has legal obligations regarding inventorship accuracy and who participated in determining the claims — is particularly credible for this purpose because the source has professional accountability for its accuracy.
For petitioners who are early-career researchers with co-invented patents, the framing strategy may shift toward establishing the progression of the petitioner's inventive contribution over time. A petitioner who contributed a peripheral claim on a co-invented patent early in their career, then became the lead inventor on a solo-invented patent three years later, then developed a patent family with 30 or more forward citations five years after that, presents a trajectory of increasing original contribution that is more persuasive than any single patent standing alone. The petition should present the full inventive record chronologically, describe the petitioner's growing leadership role in the inventive process, and identify the patent or patents that best establish major significance while explaining the others as contributing context.
Auditing and building the original contributions exhibit
A well-built patent exhibit for the original contributions criterion includes, for each relying patent: the issued patent cover page establishing the patent number, title, issue date, and named inventors; forward citation data showing citing patents and their assignees; licensing evidence if available such as a technology transfer office letter or redacted license agreement; and a source-specific expert letter describing the technical significance of the invention. These four components together address the criterion's two requirements — originality established by the patent grant, major significance established by the citations, licensing record, and expert assessment — from multiple independent angles that reinforce each other.
Before finalizing the exhibit, the petition preparer should test each relying patent against the major significance standard: Has any independent researcher or practitioner cited this patent? Has any company paid to license it? Can a recognized expert in the field explain why this patent was a meaningful advance beyond the state of the art? If the answer to all three questions is no, the patent may not satisfy the original contributions criterion standing alone and should be bundled with other evidence that collectively demonstrates major significance — or omitted from the original contributions tier and treated as supporting context in another part of the petition record.
The combination of patent evidence with the scholarly articles criterion is particularly powerful when a researcher's inventive and publishing records are integrated. A researcher who invented a novel analytical instrument, published the underlying methodology in a field-leading journal, and then received both forward citations in subsequent patent filings and citations in academic papers has a documented record of original contributions that crosses from the patent world into the scientific literature. This cross-referencing of the citation record — showing that the same underlying contribution was recognized both by subsequent inventors and by academic researchers — is among the most persuasive configurations of original contributions evidence available in an O-1A petition.
What we typically gather for this kind of case
| Document | Where to source | Why it matters |
|---|---|---|
| Peer-reviewed publications | Web of Science / Scopus exports | Anchors original-contributions and authorship criteria |
| Citation analysis | Google Scholar profile + ESI top-1% data | Quantifies major significance in the field |
| Salary benchmark | BLS OEWS for SOC code + locality | Documents high-salary criterion at 90th-percentile or above |
| Critical-role letters | Direct supervisor + program director | Establishes role's importance, not just title |
What we see go wrong, again and again
- 01Treating extraordinary ability as a credentials checklist rather than a story of field-wide impact.
- 02Submitting bibliometric data (h-index, citation counts) without explaining what makes those numbers high relative to peers in the same sub-field.
- 03Relying on letters from collaborators or co-authors rather than independent experts who can speak to influence.
See if you qualify
Lando reviews your background against the O-1 visa criteria and tells you honestly where you stand. Free, no commitment.